Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARTH: Aliskiren vs Eplerenone in Hypertensive LVH
NCT01893788Phase 4Unknown
- Sponsor
- Nagoya University
- Start
- Apr 2013
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren, eplerenone in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Nagoya University. Status: unknown.
02
Drugs
aliskireneplerenone
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT01893788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893788.